To further demonstrate the generalizability of the novel engineered 3’UTR destabilization of ERBB2 oncogene, we extended this work into the NCIH2030 ERBB2-mutated non-small-cell lung cancer cell line and the HCT116 colorectal cancer cell line. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.